List of 103 formulations
NATIONAL LIST OF ESSENTIAL MEDICINES 2011
Section: 1 – Anesthesia
1.1 General Anesthetics and Oxygen
| Sl. No. | Medicines | Category | Route of Administration | Strengths | – |
|---|---|---|---|---|---|
| 1 | Ether | S, T | Inhalation | — |
-- |
| 2 | Ketamine Hydrochloride | P, S, T | Injection | 10 mg / ml |
-- |
| 1.2 Local Anesthetics | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 3 | Lignocaine Hydrochloride | P, S, T | Spinal | 5% +7.5% Glucose |
-- |
| 1.3 Preoperative Medication and Sedation for Short Term Procedures | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 4 | Diazepam | S, T | Syrup | 2mg/5ml |
-- |
| 5 | Diazepam | Suppository | 5 mg |
-- |
|
| Section: 2 – Analgesics , Antipyretics, Nonsteroidal Anti-inflammatory Medicines, Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders |
-- |
||||
| 2.2 Opioid Analgesics |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 6 | Tramadol |
-- |
Cap | 100 mg |
-- |
| Section: 4 – Antidotes and Other Substances used in Poisonings | |||||
| 4.1: Nonspecific | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 7 | Activated Charcoal | P,S,T | Oral |
-- |
-- |
| 4.2: Specific | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 8 | Atropine Sulphate | P,S,T | Injection | 1 mg/ml |
-- |
| 9 | Methylthioninium chloride (Methylene blue) | S, T | Injection | 10 mg / ml |
-- |
| 10 | Penicillamine | S, T | Tablets or Capsules | 250 mg | 13.12 |
| 11 | Dimercaprol | S, T | Injection in oil | 50 mg / ml |
-- |
| 12 | Flumazenil | T | Injection | 0.1 mg / ml |
-- |
| 13 | Sodium Nitrite | S, T | Injection | 30 mg / ml |
-- |
| 14 | Sodium Thiosulphate | S, T | Injection | 250 mg/ ml |
-- |
| 15 | Pralidoxime Chloride(2-PAM) | P,S,T | Injection | 25 mg/ml |
-- |
| Section: 5 – Anticonvulsants/ Antiepileptics |
-- |
||||
| 16 | Phenytoin Sodium | P,S,T | Injection | 25 mg/ml |
-- |
| 17 | Sodium Valproate | P,S,T | Syrup | 500mg | 0.58 |
| Section: 6 – Anti-infective Medicines |
-- |
||||
| 6.1 Anthelminthics | |||||
| 6.1.1 Intestinal Anthelminthics | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| Added Medicines | |||||
| 18 | Piperazine | P,S,T | Tablets | 4.5 gm |
-- |
| 19 | Solution | 750mg/5ml | 0.38 | ||
| 6.2 Antibacterials | |||||
| 6.2.4 Antituberculosis medicines | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 20 | Isoniazid | P,S,T | Tablets | 50 mg |
-- |
| 6.3 Antifungal medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 21 | Nystatin | P,S,T | Tablets | 500,000 IU |
-- |
| 22 | Nystatin | P,S,T | Pessaries | 100,000 IU |
-- |
| 6.4.2 Antiretroviral medicines |
-- |
||||
| 6.4.2.1 Nucleoside reverse transcriptase inhibitors |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 23 | Zidovudine | S, T | Tablets | 100 mg |
-- |
| 24 | Stavudine | S, T | Capsules | 15 mg |
-- |
| 25 | Didanosine | S, T | Tablets | 400 mg |
-- |
| 6.4.2.2 Non-nucleoside reverse transcriptase inhibitors |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 26 | Efavirenz | S,T | Capsules | 600 mg |
-- |
| 27 | Nevirapine | S, T | Capsules | 200 mg |
-- |
| 28 | Indinavir | S, T | Capsules | 200 mg |
-- |
| 29 | Nelfinavir | S, T | Capsules | 250 mg |
-- |
| 30 | Ritonavir | S, T | Syrup | 400 mg / 5ml |
-- |
| 31 | Saquinavir | S, T | Capsules | 200 mg |
-- |
| 6.5.3.1 For curative treatment |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 32 | Pyrimethamine | P,S,T | Tablets | 25 mg |
-- |
| 33 | Clindamycin | S,T | Tablet | 150mg |
-- |
| 6.5.4 Antipneumocystosis and Antitoxoplasmosis medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 34 | Pentamidine Isothionate | S, T | Injection | 200 mg |
-- |
| Section: 8 – Antineoplastic, immunosuppressives and medicines used in palliative care |
-- |
||||
| 8.1: Immunosuppressive medicines | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 35 | Cyclosporine | T | Capsules | 10 mg |
-- |
| 8.2: Cytotoxic medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 36 | Folinic Acid | T | Injection | 3mg / ml |
-- |
| 37 | Actinomycin D | T | Injection | 0.5 mg |
-- |
| 38 | Cyclophosphamide | T | Tablets | 200 mg |
-- |
| 39 | Mercaptopurine | T | Injection | 100 mg / ml |
-- |
| Section: 10 –Medicines affecting the blood |
-- |
||||
| 10.1: Antianaemia medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 40 | Cyanocobalamin | P,S,T | Injection | 1 mg/ml |
-- |
| 41 | Ferrous Sulphate/Fumrate | P,S,T | Tablets | Tablets equivalent to 60 mg elemental iron |
-- |
| 42 | Ferrous Sulphate/Fumrate | P,S,T | Oral solution | 25mg elemental iron (as sulphate)/ml |
-- |
| 43 | Pyridoxine | P,S,T | Tablets | 10 mg |
-- |
| Section: 11 –Blood products and Plasma substitutes |
-- |
||||
| 11.1: Plasma Substitutes |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 44 | Dextran-70 | P,S,T | Injection | 6% |
-- |
| Section: 11 –Blood products and Plasma substitutes | |||||
| 11.1: Plasma Substitutes | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 45 | Fresh frozen plasma | T | Injection |
-- |
-- |
| 46 | Polygeline | S, T | Injection | 3.50% |
-- |
| 11.2: Plasma fractions for specific use | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 47 | Cryoprecipitate | S, T | Injection |
-- |
-- |
| 48 | Factor IX Complex (Coagulation Factors II,VII, IX, X) | S, T | Injection | Dried |
-- |
| 49 | Platelet Rich Plasma | S, T | Injection |
-- |
-- |
| Section: 12 –Cardiovascular medicines |
-- |
||||
| 12.2: Antiarrhythmic medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 50 | Procainamide Hydrochloride | T | Tablets | 250 mg |
-- |
| 12.4: Medicines used in heart failure |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 51 | Digoxin | S, T | Elixir | 0.05 mg/ml |
-- |
| 12.5: Antithrombotic medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 52 | Urokinase | T | Injection | 500,000 IU/ml |
-- |
| Section: 13 –Dermatological medicines (Topical) |
-- |
||||
| 13.1: Antifungal medicines | |||||
| 53 | Neomycin + Bacitracin | P,S,T | Ointment | 5 mg + 500 IU / g |
-- |
| 13.2: Antiinfective medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 54 | Methylrosanilinium Chloride (Gentian Violet) | P,S,T | Aqueous solution | 0.50% |
-- |
| 13.4: Astringent Medicines | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 55 | Zinc Oxide | P,S,T | Dusting Powder |
-- |
-- |
| 13.5: Medicines affecting skin differentiation and proliferation |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 56 | Coal Tar | P,S,T | Solution | 5% |
-- |
| 57 | Salicylic Acid | P,S,T | Solution | 5% |
-- |
| Section: 14 –Diagnostic agents |
-- |
||||
| 14.1: Ophthalmic medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 58 | Lignocaine | S, T | Eye Drops | 4% |
-- |
| 59 | Fluorescein | S, T | Eye drops | 1% |
-- |
| 14.2: Radiocontrast media |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 60 | Sodium Lothalamate | S, T | Injection | 70% w/v(Iodine =420 mg / ml) |
-- |
| 61 | Barium Sulphate | S, T | Suspension | 100% w/v |
-- |
| 62 | Barium Sulphate | 250% w/v |
-- |
||
| 63 | Calcium Ipodate | S, T | Injection | 3 g |
-- |
| 64 | Iopanoic Acid | S, T | Tablets | 500 mg |
-- |
| 65 | Meglumine Iothalamate | S, T | Injection | 60% w/v (iodine =280 mg / ml) |
-- |
| 66 | Meglumine Iotroxate | S, T | Solution | 5-8 g iodine in 100-250 ml |
-- |
| 67 | Propyliodone | S, T | Oily, suspension | 500-600 mg / ml |
-- |
| 68 | Sodium Meglumine Diatrizoate | S, T | Injection | 60% w/v(Iodine conc. =292 mg / ml) |
-- |
| 69 | Sodium Meglumine Diatrizoate | 76% w/v(Iodine conc. =370 mg / ml) |
-- |
||
| 70 | Sodium Meglumine Diatrizoate | S, T | Injection | 60% w/v(Iodine conc. =292 mg / ml) |
-- |
| Section: 15 –Disinfectants and antiseptics |
-- |
||||
| 15.1: Antiseptics |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 71 | Chlorhexidine | P, S, T | Solution | 5% (conc. for dilution) |
-- |
| 72 | Gentian Violet | P, S, T | Paint | 0.50% |
-- |
| 73 | Acriflavin+Glycerin | P, S, T | Solution |
-- |
-- |
| 15.2: Disinfectants |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 74 | Bleaching Powder | P, S, T | Powder | Contains not less than 30 % w/w of available chlorine (as per I.P) |
-- |
| 75 | Formaldehyde Solution | P, S, T | Solution | Dilute 34 ml of formaldehyde solution with water to produce 100 ml (As per I.P) |
-- |
| Section: 16 –Diuretics |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 76 | Hydrochlorothiazide | P,S,T | Tablets | 50 mg |
-- |
| Section: 17 – Gastrointestinal medicines |
-- |
||||
| 17.4: Antispasmodic medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 77 | Dicyclomine Hydrochloride | P,S,T | Tablets | 10 mg |
-- |
| Section: 17 – Gastrointestinal medicines | |||||
| 17.6.2 Antidiarrhoeal medicines | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| Medicines added | |||||
| 78 | Zinc Sulfate | P,S,T | Syrup | 20 mg/5ml |
-- |
| Section: 18 –Hormones, other endocrine medicines and contraceptives |
-- |
||||
| 18.3: Contraceptives |
-- |
||||
| 18.3.1: Hormonal Contraceptives |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 79 | Ethinylestradiol + Norethisterone | P,S,T | Tablets | 0.035 mg +1.0 mg |
-- |
| 80 | Hormone Releasing IUD | T | Levonorgesterol Releasing | IUD |
-- |
| 18.8 Thyroid and antithyroid medicines | |||||
|
-- |
Medicines | Category | Route of Administration / Dosage Form | Strengths |
-- |
| 81 | Iodine | S,T | Solution | 8 mg / 5 ml |
-- |
| Section: 19 Immunologicals | |||||
| 19.1: Diagnostic agents | |||||
|
-- |
Drugs | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 82 | Tuberculin, Purified Protein derivative | P,S,T | Injection | 1 TU |
-- |
| 83 | Tuberculin, Purified Protein derivative | 5 TU |
-- |
||
| Section: 20 – Muscle Relaxants (Peripherally acting) and Cholinesterase Inhibitors |
-- |
||||
|
-- |
Drugs | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 84 | Pyridostigmine | S, T | Injection | 1mg/ml |
-- |
| Section: 21 – Ophthalmological Preparations |
-- |
||||
| 21.1: Anti-infective agents |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 85 | Chloramphenicol | P,S,T | Drops | 0.40% | 43 |
| 86 | Chloramphenicol | P,S,T | Ointment | 0.40% | 44 |
| 87 | Miconazole | P,S,T | Drops | 1% |
-- |
| 88 | Povidone Iodine | S,T | Drops | 0.60% |
-- |
| 21.3: Local Anaesthetics |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 89 | Tetracaine Hydrochloride | P,S,T | Drops | 0.50% |
-- |
| 21.4: Miotics and Antiglucoma medicines |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 90 | Pilocarpine | S,T | Drops | 4% |
-- |
| 21.5: Mydriatics |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 91 | Phenylephrine | P,S,T | Drops | 5% |
-- |
| Section: 25 – Medicines acting on the respiratory tract |
-- |
||||
| 25.2: Antitussives |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 92 | Codeine phosphate | S,T | Tablets | 10mg |
-- |
| 93 | Codeine phosphate |
-- |
Syrup | 15mg/ 5ml | 42 |
| 94 | Dextromethorphan | P,S,T | Tablets | 30mg |
-- |
| Section: 26 – Solutions correcting water, electrolyte and acid-base disturbances |
-- |
||||
| 26.2: Parenteral |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 95 | Glucose | P, S, T | Injection | 15% |
-- |
| 96 | N/2 Saline | S, T | Injection |
-- |
-- |
| 97 | N/5 Saline | S, T | Injection |
-- |
-- |
| 98 | Potassium Chloride | P, S, T | Injection | 11.2% Sol. |
-- |
| 26.3: Miscellaneous | |||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 99 | Water for Injection | P, S, T | Injection | 2 ml |
-- |
| Section: 27 – Vitamins and Minerals |
-- |
||||
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 100 | Pyridoxine | P,S,T | Tablets | 25 mg |
-- |
|
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths |
-- |
| 101 | Nicotinamide | P,S,T | Tablets | 50 mg |
-- |
| 102 | Vitamin D (Ergocalciferol) | P,S,T | Capsules | 0.25 mg |
-- |
| 103 | Vitamin D (Ergocalciferol) | Capsules | 1 mg |
-- |
|
Last Page Updated: 18-01-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)